Target intelligence / Profile preview

Dietary protein substrates in gastric lumen

Molecular classification
Substrate, Macronutrient, Polypeptide
01

Overview

Dietary protein substrates in the gastric lumen are the initial forms of ingested nitrogenous compounds that undergo proteolysis in the stomach. The process begins with the action of pepsin, an enzyme activated by gastric acid, which cleaves proteins into smaller peptide fragments (StatPearls: Physiology, Digestion, 2023). These substrates are critical for stimulating the cephalic and gastric phases of digestion, including the secretion of gastrin and cholecystokinin (NIH: Digestive System, 2023). In patients with digestive disorders such as exocrine pancreatic insufficiency or cystic fibrosis, these substrates are the targets of pancreatic enzyme replacement therapy (PERT) to prevent malabsorption (Mayo Clinic: Pancreatitis Treatment, 2023). Additionally, specific dietary proteins like gluten are targeted by novel endopeptidases in development for Celiac disease to neutralize toxic epitopes before they reach the small intestine (ClinicalTrials.gov: Latiglutenase, 2024). Monitoring the breakdown of these substrates is essential for assessing gastrointestinal function and the efficacy of supplemental digestive aids. Therapeutic intervention typically involves the oral administration of enzymes that catalyze the hydrolysis of these proteins within the acidic or neutralizing environment of the stomach and proximal duodenum (PubChem: Pancrelipase, 2024).

Other names
Ingested proteinAlimentary proteinGastric proteinDietary polypeptidesFood-derived protein
02

Mechanism of action

Enzymatic hydrolysis of peptide bonds to facilitate absorption or neutralize immunogenic epitopes.

03

Biological functions

ProteolysisNitrogen balanceAmino acid supplyGastrin secretion stimulationSatiety signaling
04

Disease associations

Exocrine pancreatic insufficiencyCeliac diseaseMalabsorptionFood allergyCystic fibrosisGastroparesis
05

Safety considerations

Allergic reactions to exogenous enzymesHyperuricosuria (with high-dose pancrelipase)Fibrosing colonopathypH-dependent enzyme inactivation
06

Interacting drugs

Pancrelipase

4 more in the full profile.

07

Biomarkers

Fecal elastase-113C-labeled protein breath testPlasma amino acid levelsFecal nitrogenSerum albumin

Beyond the preview

Go deeper on Dietary protein substrates in gastric lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary protein substrates in gastric lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call